FDA Inspection 1032327 — Gulf Coast Regional Blood Center
The FDA completed an inspection of Gulf Coast Regional Blood Center on Nov 7, 2017 in Sugar Land, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Sugar Land, TX (United States)